REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 80 filers reported holding REVANCE THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.49 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $694 | +402.9% | 21,549 | +188.8% | 0.01% | +300.0% |
| Q4 2022 | $138 | -100.0% | 7,462 | -34.6% | 0.00% | -50.0% |
| Q3 2022 | $308,000 | -67.4% | 11,402 | -66.4% | 0.00% | 0.0% |
| Q3 2021 | $946,000 | +332.0% | 33,961 | +360.0% | 0.00% | +300.0% |
| Q2 2021 | $219,000 | -44.0% | 7,383 | -47.2% | 0.00% | -50.0% |
| Q1 2021 | $391,000 | +191.8% | 13,993 | +195.3% | 0.00% | +100.0% |
| Q4 2020 | $134,000 | -89.1% | 4,738 | -90.3% | 0.00% | -87.5% |
| Q3 2020 | $1,234,000 | +100.3% | 49,081 | +94.5% | 0.01% | +60.0% |
| Q2 2020 | $616,000 | +321.9% | 25,230 | +155.6% | 0.01% | +400.0% |
| Q1 2020 | $146,000 | +13.2% | 9,870 | +24.5% | 0.00% | 0.0% |
| Q4 2019 | $129,000 | -25.4% | 7,926 | -27.8% | 0.00% | -50.0% |
| Q1 2019 | $173,000 | +20.1% | 10,981 | +109.9% | 0.00% | +100.0% |
| Q3 2017 | $144,000 | -35.1% | 5,231 | -51.3% | 0.00% | -50.0% |
| Q4 2016 | $222,000 | +73.4% | 10,734 | +46.0% | 0.00% | +100.0% |
| Q1 2016 | $128,000 | +21.9% | 7,351 | +123.4% | 0.00% | 0.0% |
| Q2 2015 | $105,000 | – | 3,291 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 4,592,047 | $156,130,000 | 32.47% |
| Camber Capital Management LP | 630,000 | $21,420,000 | 1.40% |
| Granite Point Capital Management, L.P. | 50,000 | $1,700,000 | 1.17% |
| Rhenman & Partners Asset Management AB | 82,000 | $2,788,000 | 0.83% |
| Geduld E E | 25,001 | $850,000 | 0.53% |
| Pier Capital, LLC | 106,985 | $3,637,000 | 0.52% |
| Ghost Tree Capital, LLC | 20,000 | $680,000 | 0.48% |
| ArrowMark Colorado Holdings LLC | 433,457 | $14,738,000 | 0.42% |
| Polar Capital LLP | 577,042 | $19,618,000 | 0.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 256,500 | $8,721,000 | 0.35% |